Quick Take
- Temple, founded by Deepinder Goyal, hit a $375 Mn (Rs 3,608 Cr) valuation via a secondary share sale.
- The figure is nearly double the $190 Mn mark set in its February 2026 seed round of $54 Mn.
- Temple ran its first ESOP buyback, letting about 20 staff sell part of their vested options.
In This Article
The Temple valuation has nearly doubled to $375 Mn (Rs 3,608 Cr) through a secondary share sale, and founder Deepinder Goyal has launched the wearable startup’s first ESOP (Employee Stock Ownership Plan) liquidity programme. Moneycontrol reported the deal on July 27, 2026.
The new mark is almost twice the roughly $190 Mn (Rs 1,715 Cr) post-money value Temple carried after its $54 Mn (Rs 493 Cr) seed round in February 2026. The jump comes as the company builds a forehead-worn health wearable and prepares for a wider commercial launch. Goyal stepped down as CEO of Eternal (Zomato’s parent) before starting Temple.
StartupFeed Insight
The most telling number is not $375 Mn, it is the timing. Temple ran this buyback at a rising valuation, not a discount, which is rare for a pre-revenue hardware startup. That signals Goyal is using founder capital and early Zomato goodwill to lock in talent before external money arrives at a reported $500 Mn (Rs 4,810 Cr) ask. Hardware founders and deep-tech VCs should watch closely: if Temple closes that round on those terms, it resets the price ceiling for Indian health wearables. Expect Temple to confirm a priced institutional round before March 2027. By Avinash.
The Temple Valuation Numbers
The Temple valuation reached $375 Mn (Rs 3,608 Cr) in a secondary transaction, where existing shareholders sell shares rather than the company issuing new stock. Moneycontrol first reported the figures from an internal company memo.
| Metric | Detail | Notes |
|---|---|---|
| New Valuation | $375 Mn (Rs 3,608 Cr) | Secondary share sale, Moneycontrol |
| Previous Valuation | $190 Mn (Rs 1,715 Cr) | Post-money, February 2026, RoC filing |
| Seed Round Raised | $54 Mn (Rs 493 Cr) | Led by Deepinder Goyal |
| ESOP Eligibility | ~20 employees, up to 25% | Of vested options, per company memo |
| Next Round Interest | $500 Mn (Rs 4,810 Cr) | Reported external interest, not closed |
The standout detail is that the buyback price sits above the last round. Most early-stage ESOP sales happen at a markdown, so a higher mark shows unusual demand for Temple stock.
About Temple
Temple is a wearable technology startup founded in 2026 by Deepinder Goyal, the Zomato co-founder, after he stepped down as Eternal CEO. Headquartered in India, the company is building a non-invasive, forehead-worn device that tracks the body’s metabolic state and brain blood flow in real time. Its early backers include Steadview Capital, Peak XV Partners, and Zerodha co-founder Nikhil Kamath, per RoC filings reviewed by TechCrunch.
Why did Temple run an ESOP buyback now?
Temple ran the ESOP buyback to reward early staff before its next funding round closes. Around 20 employees can sell up to 25% of their vested options at the new valuation. In a memo to staff, founder Deepinder Goyal explained the reasoning.
We are seeing strong interest from external investors at a $500 million valuation. Before we close our next round, I want some of this value to reach the people who created it, Deepinder Goyal said.
The buyback lets employees convert paper gains into cash while the company stays private. It also rewards the more than 30 staff who invested their own money in the February seed round at the same terms as outside investors.
How does this compare to other startup buybacks?
ESOP buybacks have become a common wealth tool across India’s startup sector in 2026. Nine startups have together completed buybacks worth more than $270 Mn (Rs 2,597 Cr) this year, according to data compiled by Entrackr.
| Company | Sector | 2026 Buyback Move |
|---|---|---|
| Temple | Healthtech wearable | First buyback, above last round |
| Scapia | Travel fintech | Rs 20 Cr buyback |
| BrowserStack, CoinDCX, Plum | SaaS, crypto, insurtech | Among nine 2026 programmes |
What makes Temple different is its stage. Most companies on that list have revenue and scale, while Temple is running a buyback before its first product even ships commercially.
What’s Next
Temple plans to launch its health wearable commercially within the next year, priced between Rs 75,000 and Rs 80,000, subject to further validation. A priced external funding round at or near the reported $500 Mn (Rs 4,810 Cr) mark is the next milestone to watch. Will investors pay a premium for a wearable that has yet to prove mass-market demand?
Frequently Asked Questions
Disclaimer: This article is for informational purposes only and does not constitute investment advice. StartupFeed and its authors are not SEBI-registered investment advisors. The analysis above is based on publicly available information and should not be the sole basis for any investment decision. Please consult a SEBI-registered financial advisor before making investment decisions.
Have a tip? Write to us at editorial@startupfeed.in.
